Clinical Trials in Dallas

Showing 3241-3260 of 15,003 trials

Study to Evaluate the Efficacy & Safety of the INTERCEPT Blood System for RBCs in Complex Cardiac Surgery Patients

NCT03459287

The objective of this study is to evaluate the efficacy and safety of RBC transfusion for support of acute anemia in cardiovascular surgery patients based on the clinical outcome of renal impairment following transfusion of red blood cells (RBCs) treated with the INTERCEPT Blood System (IBS) for Red Blood Cells compared to patients transfused with conventional RBCs.

Anemia

Cerus Corporation581 participantsStarted Dec 2018

Los Angeles, California, United States • Stanford, California, United States • Aurora, Colorado, United States +15 more locations

Active Not RecruitingPhase 3< 1 mile

Evaluation of Rifaximin SSD for Delaying Encephalopathy Decompensation in Patients With Cirrhosis

NCT05297448

Study RNLC3132 is a Phase 3, randomized, double-blind, placebo-controlled, multicenter study to assess the efficacy and safety of rifaximin SSD-40mg IR for the delay of the first episode of overt hepatic encephalopathy (OHE) decompensation in liver cirrhosis, defined by the presence of medically controlled ascites.

Hepatic Encephalopathy

Bausch Health Americas, Inc.466 participantsStarted Aug 2022

Homewood, Alabama, United States • Chandler, Arizona, United States • Sun City, Arizona, United States +185 more locations

Study to Evaluate the Efficacy & Safety of the INTERCEPT Blood System for RBCs in Complex Cardiac Surgery Patients

Evaluation of Rifaximin SSD for Delaying Encephalopathy Decompensation in Patients With Cirrhosis

Find Trials by Condition in Dallas

Omalizumab as Monotherapy and as Adjunct Therapy to Multi-Allergen OIT in Food Allergic Participants

Periprostatic Neurolysis in Prostate Cancer

A Study of LM-24C5 For Advanced Solid Tumors

A Study of Relatlimab Plus Nivolumab Versus Nivolumab Alone in Participants With Advanced Melanoma

Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers

PLAN Intervention to Enhance Engagement of Latino Cancer Patients in Advanced Care Planning

A Safety/Tolerability and PK Study With Azstarys® in Children With ADHD

FebriDx® Method Comparison Study Protocol

A Study of Belrestotug Plus Dostarlimab Compared With Placebo Plus Pembrolizumab in Previously Untreated Participants With Programmed Death Ligand 1 (PD-L1) High Non-small-cell Lung Cancer (NSCLC)

Study of an Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and Toddlers

Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer

A Phase I/II Study of Hypofractionated Proton Therapy for Stage II-III Non-Small Cell Lung Cancer

A Phase 2 Study of YA-101 in Patients With Multiple System Atrophy

PNOC 001: Phase II Study of Everolimus for Recurrent or Progressive Low-grade Gliomas in Children

Study of Cabozantinib in Combination With Nivolumab and Ipilimumab in Patients With Previously Untreated Advanced or Metastatic Renal Cell Carcinoma

PRI-VENT FSGS: Preemptive Rituximab to Prevent Recurrent Focal Segmental Glomerulosclerosis Post-Transplant

A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression

First-in-Human Study of OKI-219 in Advanced Solid Tumors and Advanced Breast Cancer